Literature DB >> 29950411

Human MxB Protein Is a Pan-herpesvirus Restriction Factor.

Mirjam Schilling1, Lorenzo Bulli2, Sebastian Weigang1, Laura Graf1, Sebastian Naumann1, Corinna Patzina1, Valentina Wagner1, Liane Bauersfeld1, Caroline Goujon3, Hartmut Hengel1,4,5, Anne Halenius1,4, Zsolt Ruzsics1,4,5, Torsten Schaller2, Georg Kochs6,4.   

Abstract

Herpesvirus infections are highly prevalent in the human population and persist for life. They are often acquired subclinically but potentially progress to life-threatening diseases in immunocompromised individuals. The interferon system is indispensable for the control of herpesviral replication. However, the responsible antiviral effector mechanisms are not well characterized. The type I interferon-induced, human myxovirus resistance 2 (MX2) gene product MxB, a dynamin-like large GTPase, has recently been identified as a potent inhibitor of HIV-1. We now show that MxB also interferes with an early step of herpesvirus replication, affecting alpha-, beta-, and gammaherpesviruses before or at the time of immediate early gene expression. Defined MxB mutants influencing GTP binding and hydrolysis revealed that the effector mechanism against herpesviruses is thoroughly different from that against HIV-1. Overall, our findings demonstrate that MxB serves as a broadly acting intracellular restriction factor that controls the establishment of not only retrovirus but also herpesvirus infection of all three subfamilies.IMPORTANCE Human herpesviruses pose a constant threat to human health. Reactivation of persisting herpesvirus infections, particularly in immunocompromised individuals and the elderly, can cause severe diseases, such as zoster, pneumonia, encephalitis, or cancer. The interferon system is relevant for the control of herpesvirus replication as exemplified by fatal disease outcomes in patients with primary immunodeficiencies. Here, we describe the interferon-induced, human MX2 gene product MxB as an efficient restriction factor of alpha-, beta-, and gammaherpesviruses. MxB has previously been described as an inhibitor of HIV-1. Importantly, our mutational analyses of MxB reveal an antiviral mechanism of herpesvirus restriction distinct from that against HIV-1. Thus, the dynamin-like MxB GTPase serves as a broadly acting intracellular restriction factor that controls retrovirus as well as herpesvirus infections.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  HCMV; HSV-1; MHV68; MxB protein; cytomegalovirus; herpes simplex virus; herpesviruses; human MX2 gene; innate immunity; interferons

Mesh:

Substances:

Year:  2018        PMID: 29950411      PMCID: PMC6096802          DOI: 10.1128/JVI.01056-18

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Inhibition of nuclear import and cell-cycle progression by mutated forms of the dynamin-like GTPase MxB.

Authors:  Megan C King; Graça Raposo; Mark A Lemmon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-07       Impact factor: 11.205

2.  Polymerase chain reaction for identification of herpes simplex virus (HSV-1), cytomegalovirus (CMV) and human herpes virus-type 6 (HHV-6) in oral swabs.

Authors:  Jùnia Maria Netto Victória; André Luiz Sena Guimarães; Luciano Marques da Silva; Evanguedes Kalapothakis; Ricardo Santiago Gomez
Journal:  Microbiol Res       Date:  2005       Impact factor: 5.415

3.  Virus progeny of murine cytomegalovirus bacterial artificial chromosome pSM3fr show reduced growth in salivary Glands due to a fixed mutation of MCK-2.

Authors:  Stefan Jordan; Johannes Krause; Adrian Prager; Maja Mitrovic; Stipan Jonjic; Ulrich H Koszinowski; Barbara Adler
Journal:  J Virol       Date:  2011-08-03       Impact factor: 5.103

4.  Systematic identification of type I and type II interferon-induced antiviral factors.

Authors:  Su-Yang Liu; David Jesse Sanchez; Roghiyh Aliyari; Sun Lu; Genhong Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-27       Impact factor: 11.205

5.  Genome-scale CRISPR-Cas9 knockout screening in human cells.

Authors:  Ophir Shalem; Neville E Sanjana; Ella Hartenian; Xi Shi; David A Scott; Tarjei Mikkelson; Dirk Heckl; Benjamin L Ebert; David E Root; John G Doench; Feng Zhang
Journal:  Science       Date:  2013-12-12       Impact factor: 47.728

6.  Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency.

Authors:  Stéphanie Dupuis; Emmanuelle Jouanguy; Sami Al-Hajjar; Claire Fieschi; Ibrahim Zaid Al-Mohsen; Suliman Al-Jumaah; Kun Yang; Ariane Chapgier; Céline Eidenschenk; Pierre Eid; Abdulaziz Al Ghonaium; Haysam Tufenkeji; Husn Frayha; Suleiman Al-Gazlan; Hassan Al-Rayes; Robert D Schreiber; Ion Gresser; Jean-Laurent Casanova
Journal:  Nat Genet       Date:  2003-02-18       Impact factor: 38.330

Review 7.  Mx GTPases: dynamin-like antiviral machines of innate immunity.

Authors:  Otto Haller; Peter Staeheli; Martin Schwemmle; Georg Kochs
Journal:  Trends Microbiol       Date:  2015-01-06       Impact factor: 17.079

8.  A capsid-encoded PPxY-motif facilitates adenovirus entry.

Authors:  Harald Wodrich; Daniel Henaff; Baptist Jammart; Carolina Segura-Morales; Sigrid Seelmeir; Olivier Coux; Zsolt Ruzsics; Christopher M Wiethoff; Eric J Kremer
Journal:  PLoS Pathog       Date:  2010-03-19       Impact factor: 6.823

9.  Targeted deletion of regions rich in immune-evasive genes from the cytomegalovirus genome as a novel vaccine strategy.

Authors:  Luka Cicin-Sain; Ivan Bubić; Margit Schnee; Zsolt Ruzsics; Christian Mohr; Stipan Jonjić; Ulrich H Koszinowski
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

10.  Transfer of the amino-terminal nuclear envelope targeting domain of human MX2 converts MX1 into an HIV-1 resistance factor.

Authors:  Caroline Goujon; Olivier Moncorgé; Hélène Bauby; Tomas Doyle; Wendy S Barclay; Michael H Malim
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

View more
  31 in total

Review 1.  Human MX2/MxB: a Potent Interferon-Induced Postentry Inhibitor of Herpesviruses and HIV-1.

Authors:  Peter Staeheli; Otto Haller
Journal:  J Virol       Date:  2018-11-27       Impact factor: 5.103

2.  MxB Restricts HIV-1 by Targeting the Tri-hexamer Interface of the Viral Capsid.

Authors:  Sarah Sierra Smaga; Chaoyi Xu; Brady James Summers; Katherine Marie Digianantonio; Juan R Perilla; Yong Xiong
Journal:  Structure       Date:  2019-05-30       Impact factor: 5.006

3.  GTPase Activity of MxB Contributes to Its Nuclear Location, Interaction with Nucleoporins and Anti-HIV-1 Activity.

Authors:  Linlin Xie; Zhao Ju; Chaojie Zhong; Yingjun Wu; Yuxing Zan; Wei Hou; Yong Feng
Journal:  Virol Sin       Date:  2020-07-06       Impact factor: 4.327

4.  Pro-515 of the dynamin-like GTPase MxB contributes to HIV-1 inhibition by regulating MxB oligomerization and binding to HIV-1 capsid.

Authors:  Fengwen Xu; Fei Zhao; Xiaoxiao Zhao; Di Zhang; Xiaoman Liu; Siqi Hu; Shan Mei; Zhangling Fan; Yu Huang; Hong Sun; Liang Wei; Chao Wu; Quanjie Li; Jianwei Wang; Shan Cen; Chen Liang; Fei Guo
Journal:  J Biol Chem       Date:  2020-03-26       Impact factor: 5.157

5.  Mouse Mx1 Inhibits Herpes Simplex Virus Type 1 Genomic Replication and Late Gene Expression In Vitro and Prevents Lesion Formation in the Mouse Zosteriform Model.

Authors:  Melkamu B Tessema; Rubaiyea Farrukee; Christopher E Andoniou; Mariapia A Degli-Esposti; Clare V Oates; James B Barnes; Linda M Wakim; Andrew G Brooks; Sarah L Londrigan; Patrick C Reading
Journal:  J Virol       Date:  2022-05-31       Impact factor: 6.549

6.  Interferon Regulatory Factor 7 Attenuates Chronic Gammaherpesvirus Infection.

Authors:  K E Johnson; C A Aurubin; C N Jondle; P T Lange; V L Tarakanova
Journal:  J Virol       Date:  2020-11-23       Impact factor: 5.103

7.  Human MxB Inhibits the Replication of Hepatitis C Virus.

Authors:  Dong-Rong Yi; Ni An; Zhen-Long Liu; Feng-Wen Xu; Kavita Raniga; Quan-Jie Li; Rui Zhou; Jing Wang; Yong-Xin Zhang; Jin-Ming Zhou; Lei-Liang Zhang; Jing An; Cheng-Feng Qin; Fei Guo; Xiao-Yu Li; Chen Liang; Shan Cen
Journal:  J Virol       Date:  2018-12-10       Impact factor: 5.103

8.  Purification and Characterization of MxB.

Authors:  Frances Joan D Alvarez; Peijun Zhang
Journal:  Methods Mol Biol       Date:  2020

9.  Effect of Different Nuclear Localization Signals on the Subcellular Localization and Anti-HIV-1 Function of the MxB Protein.

Authors:  Keli Chai; Zhen Wang; Qinghua Pan; Juan Tan; Wentao Qiao; Chen Liang
Journal:  Front Microbiol       Date:  2021-05-20       Impact factor: 5.640

10.  Highly-potent, synthetic APOBEC3s restrict HIV-1 through deamination-independent mechanisms.

Authors:  Mollie M McDonnell; Suzanne C Karvonen; Amit Gaba; Ben Flath; Linda Chelico; Michael Emerman
Journal:  PLoS Pathog       Date:  2021-06-25       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.